Last reviewed · How we verify
ENN0403 capsules, low dose
ENN0403 capsules, low dose, is an investigational drug with unknown mechanism of action.
At a glance
| Generic name | ENN0403 capsules, low dose |
|---|---|
| Sponsor | EnnovaBio |
| Modality | Small molecule |
| Phase | Phase 2 |
Mechanism of action
Further research is needed to understand the exact mechanism of action of ENN0403 capsules, low dose.
Approved indications
Common side effects
Key clinical trials
- A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME (PHASE2)
- Efficacy and Safety of ENN0403 in Patients At High Risk for Acute Kidney Injury Following Elective Cardiac Surgery (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |